NEUTRA CORP. (NTRR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US64129C3034
Price
0.00 USD
Market cap
291,789.91 USD
P/E (2026)
–
P/S (2026)
0.29
Dividend yield
0.00 %
Net margin
-0.68 %
Return on equity (ROE)
3.20 %
Return on assets (ROA)
-4.03 %
NEUTRA CORP. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 68,057.00 USD | 1.02 m USD |
| Gross profit | 63,233.00 USD | 656,763.00 USD |
| Operating income | -105,425.00 USD | 87,489.00 USD |
| Net income | -109,023.00 USD | -6,941.00 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NEUTRA CORP.
Neutra Corp. researches, develops, and provides hemp-derived products in the nutraceutical space in the United States. The company sells hemp-derived products, including products containing delta-8-THC and other cannabinoids, CBD sports creams, and other products. Neutra Corp. was incorporated in 2011 and is based in Houston, Texas.
More stocks
- Purebase Corp (PUBC)
- Stardust Power Inc. (SDST)
- WASTE ENERGY CORP. (WAST)
- Hypha Labs, Inc. (FUNI)
- Enertopia Corp. (ENRT)
- Stemtech Corp (STEK)
- NITCHES INC (NICH)
- Natural Resource Holdings, Inc. (NRHI)
- Fyntechnical Innovations Inc (FYNN)
- FOXO TECHNOLOGIES INC. (FOXO)
- AMAZE HOLDINGS, INC. (AMZE)
- Maison Solutions Inc. (MSS)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.